Live from Wealth Expo Colombia 2026: WikiFX Strengthens Growing Partnerships Across LATAM
Live from Wealth Expo Colombia 2026: WikiFX Strengthens Growing Partnerships Across LATAM
Original
Global Broker Regulation Inquiry App
About WikiFX
English
简体中文
繁體中文
English
Pусский
日本語
ภาษาไทย
Tiếng Việt
Bahasa Indonesia
Español
हिन्दी
Filippiiniläinen
Français
Deutsch
Português
Türkçe
한국어
العربية
اردو
CLSA Premium Ltd, a Forex Broker, Has Entered Into A Strategic Partnership With TRT International
Abstract：CLSA Premium Ltd (HKG:6877), formerly KVB Kunlun, and Beijing Tong Ren Tang (Cayman) Limited (TRT International), a forex broker, have signed a strategic partnership agreement to expand healthcare businesses (including Chinese medicine).
CLSA Premium Ltd (HKG:6877), formerly KVB Kunlun, and Beijing Tong Ren Tang (Cayman) Limited (TRT International), a forex broker, have signed a strategic partnership agreement to expand healthcare businesses (including Chinese medicine).
The collaboration will involve, among other things:
TRT International will provide technical help to the Company in the areas of healthcare product specialization, procurement channel, product development, and Chinese medicine application.
TRT International will give training to the company on the healthcare industry and Chinese medicine.
TRT International will second employees with healthcare expertise to the company.
Network-building - The Company and TRT International will reciprocally introduce their networks and individuals in the healthcare industry (including Chinese medicine) to improve, among other things, network building.
Further Partnership - Subject to the evolution of healthcare business collaboration and market circumstances, the Company and TRT International may evaluate potential or reciprocal investment or assistance to each other.
The license to sell Chinese medicines - Given that the Group has a wholesaler license in proprietary Chinese medicines, it shall offer appropriate support and a route to TRT International for TRT International to distribute Chinese medicines in the Greater China area.
“The Board believes that entering into the Strategic Cooperation Agreement would enable the Group to leverage on the expertise of the TRT International group for expanding the modular management and expansion of healthcare products businesses (including Chinese medicine), and would play a positive role in diversifying the Group's revenue stream,” CLSA Premium said.
ContentsAbout CLSA Premium
CLSA Premium Ltd, originally KVB Kunlun Financial Group Ltd, is an investment holding firm that specializes in leveraged foreign exchange, commodities, and index trading.
Check out more of CLSA Premium here: https://www.wikifx.com/en/dealer/8431304120.html
Stay tuned for more Forex broker news.
Download the WikiFX App from the App Store or Google Play Store to stay updated on the latest news.
Disclaimer:
The views in this article only represent the author's personal views, and do not constitute investment advice on this platform. This platform does not guarantee the accuracy, completeness and timeliness of the information in the article, and will not be liable for any loss caused by the use of or reliance on the information in the article.
Further Reading
Live from Wealth Expo Colombia 2026: WikiFX Strengthens Growing Partnerships Across LATAM
Live from Wealth Expo Colombia 2026: WikiFX Strengthens Growing Partnerships Across LATAM
Original
XTB Exposure Report 2026: Mounting KYC & Fund Withdrawal Complaints
XTB, a veteran with over 15 years of experience in the competitive brokerage industry, has reportedly been facing severe user allegations concerning a tedious KYC verification process and blocked withdrawals despite numerous requests by traders globally. Traders worldwide, including those from the United States and the United Kingdom, have objected to the broker’s operational methodology in 2026. If you are one of them, this XTB review is worth reading! In this article, we have examined several user allegations to understand their concerns. Additionally, we have shared our analysis on the XTB regulation status. The holistic approach adopted by us will likely help you make an informed brokerage decision.
Original
Globinok Review 2026: Traders Cry Foul as Funds Disappear from the Platform
Globinok, a Comoros-based new-age trading enterprise, is receiving bad reviews from users across India, in particular. These users have accused the brokerage firm of failing to deliver on their trading promise. This included failing to ensure the AI-based trading experience promised by them. The sudden disappearance of the account manager has been another key complaint highlighted by users. In this Globinok review article, we have shared user reviews and a regulatory overview of the broker.
Original
WikiFX Broker
Latest News
FBS Review 2025: Is This Forex Broker Safe?
WikiFXWhy Good Trading Results Hide Terrible Decisions
WikiFXCrude Retreats Amid Digital Dollar Growth
WikiFXWhy Forex Breakouts Trap Beginners and How Pullbacks Actually Work
WikiFXXTB Exposure Report 2026: Mounting KYC & Fund Withdrawal Complaints
WikiFXHow a US Yield Curve Inversion Quietly Moves Major Forex Pairs
WikiFXIQ Option Review: Regulation Warnings, Broker Complaints, and Withdrawal Blocks
WikiFXBYBIT Review: Unregulated Broker Complaints Point to Frozen Funds and Withdrawal Blocks
WikiFXWhy Forex Spreads Suddenly Widen During Major Economic Releases
WikiFXThe Cost of Chasing Price Action Instead of Waiting for Quality Setups
WikiFXCurrency Calculator
USD
CNY
Current Rate:0
Enter amount
USD
Redeemable Amount
CNY
Calculate 